However, meta-analyses show an overall beneficial effect for Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in primary and secondary prevention of AF [48], [49], especially in patients already suffering from recurrent AF or with concomitant diseases like hypertension or heart failure. The gene discussed is ACE; the disease is hypertensive disorder.